205 related articles for article (PubMed ID: 12084931)
1. Urokinase-urokinase receptor interaction mediates an inhibitory signal for HIV-1 replication.
Alfano M; Sidenius N; Panzeri B; Blasi F; Poli G
Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8862-7. PubMed ID: 12084931
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HIV replication by the plasminogen activator is dependent on vitronectin-mediated cell adhesion.
Elia C; Cassol E; Sidenius N; Blasi F; Castagna A; Poli G; Alfano M
J Leukoc Biol; 2007 Nov; 82(5):1212-20. PubMed ID: 17704294
[TBL] [Abstract][Full Text] [Related]
3. Ligand-engaged urokinase-type plasminogen activator receptor and activation of the CD11b/CD18 integrin inhibit late events of HIV expression in monocytic cells.
Alfano M; Mariani SA; Elia C; Pardi R; Blasi F; Poli G
Blood; 2009 Feb; 113(8):1699-709. PubMed ID: 18941116
[TBL] [Abstract][Full Text] [Related]
4. Urokinase plasminogen activator inhibits HIV virion release from macrophage-differentiated chronically infected cells via activation of RhoA and PKCε.
Graziano F; Elia C; Laudanna C; Poli G; Alfano M
PLoS One; 2011; 6(8):e23674. PubMed ID: 21858203
[TBL] [Abstract][Full Text] [Related]
5. The role of urokinase-type plasminogen activator (uPA)/uPA receptor in HIV-1 infection.
Alfano M; Sidenius N; Blasi F; Poli G
J Leukoc Biol; 2003 Nov; 74(5):750-6. PubMed ID: 12960238
[TBL] [Abstract][Full Text] [Related]
6. Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells.
Biswas P; Poli G; Kinter AL; Justement JS; Stanley SK; Maury WJ; Bressler P; Orenstein JM; Fauci AS
J Exp Med; 1992 Sep; 176(3):739-50. PubMed ID: 1512539
[TBL] [Abstract][Full Text] [Related]
7. Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate.
Picone R; Kajtaniak EL; Nielsen LS; Behrendt N; Mastronicola MR; Cubellis MV; Stoppelli MP; Pedersen S; Danø K; Blasi F
J Cell Biol; 1989 Feb; 108(2):693-702. PubMed ID: 2537321
[TBL] [Abstract][Full Text] [Related]
8. Soluble tumor necrosis factor receptors inhibit phorbol myristate acetate and cytokine-induced HIV-1 expression chronically infected U1 cells.
Granowitz EV; Saget BM; Angel JB; Wang MZ; Wang A; Dinarello CA; Skolnik PR
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(5):430-7. PubMed ID: 8605587
[TBL] [Abstract][Full Text] [Related]
9. The receptor for urokinase-type plasminogen activator and urokinase is translocated from two distinct intracellular compartments to the plasma membrane on stimulation of human neutrophils.
Plesner T; Ploug M; Ellis V; Rønne E; Høyer-Hansen G; Wittrup M; Pedersen TL; Tscherning T; Danø K; Hansen NE
Blood; 1994 Feb; 83(3):808-15. PubMed ID: 8298141
[TBL] [Abstract][Full Text] [Related]
10. Urokinase plasminogen activator surface receptor restricts HIV-1 replication by blocking virion release from the cell membrane.
Pang H; Ouyang J; Yang Z; Shang H; Liang G
Proc Natl Acad Sci U S A; 2023 Jan; 120(3):e2212991120. PubMed ID: 36638209
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors.
Ellis V; Wun TC; Behrendt N; Rønne E; Danø K
J Biol Chem; 1990 Jun; 265(17):9904-8. PubMed ID: 2161846
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase C mediates up-regulation of urokinase and its receptor in the migrating keratinocytes of wounded cultures, but urokinase is not required for movement across a substratum in vitro.
Ando Y; Jensen PJ
J Cell Physiol; 1996 Jun; 167(3):500-11. PubMed ID: 8655604
[TBL] [Abstract][Full Text] [Related]
13. Cell-surface acceleration of urokinase-catalyzed receptor cleavage.
Høyer-Hansen G; Ploug M; Behrendt N; Rønne E; Danø K
Eur J Biochem; 1997 Jan; 243(1-2):21-6. PubMed ID: 9030717
[TBL] [Abstract][Full Text] [Related]
14. Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor.
Nykjaer A; Kjøller L; Cohen RL; Lawrence DA; Garni-Wagner BA; Todd RF; van Zonneveld AJ; Gliemann J; Andreasen PA
J Biol Chem; 1994 Oct; 269(41):25668-76. PubMed ID: 7929271
[TBL] [Abstract][Full Text] [Related]
15. Functional analysis of the cellular receptor for urokinase in plasminogen activation. Receptor binding has no influence on the zymogenic nature of pro-urokinase.
Ellis V
J Biol Chem; 1996 Jun; 271(25):14779-84. PubMed ID: 8662951
[TBL] [Abstract][Full Text] [Related]
16. The pro-urokinase plasminogen-activation system in the presence of serpin-type inhibitors and the urokinase receptor: rescue of activity through reciprocal pro-enzyme activation.
Behrendt N; List K; Andreasen PA; Danø K
Biochem J; 2003 Apr; 371(Pt 2):277-87. PubMed ID: 12534347
[TBL] [Abstract][Full Text] [Related]
17. The thalidomide analogue CC-3052 inhibits HIV-1 and tumour necrosis factor-alpha (TNF-alpha) expression in acutely and chronically infected cells in vitro.
La Maestra L; Zaninoni A; Marriott JB; Lazzarin A; Dalgleish AG; Barcellini W
Clin Exp Immunol; 2000 Jan; 119(1):123-9. PubMed ID: 10606973
[TBL] [Abstract][Full Text] [Related]
18. Role of protein kinase C in tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator.
Niedbala MJ; Stein-Picarella M
Blood; 1993 May; 81(10):2608-17. PubMed ID: 7683925
[TBL] [Abstract][Full Text] [Related]
19. The urokinase-receptor (CD87) is expressed in cells of the megakaryoblastic lineage.
Wohn KD; Kanse SM; Deutsch V; Schmidt T; Eldor A; Preissner KT
Thromb Haemost; 1997 Mar; 77(3):540-7. PubMed ID: 9066008
[TBL] [Abstract][Full Text] [Related]
20. Urokinase receptor mRNA level and gene transcription are strongly and rapidly increased by phorbol myristate acetate in human monocyte-like U937 cells.
Lund LR; Rønne E; Roldan AL; Behrendt N; Rømer J; Blasi F; Danø K
J Biol Chem; 1991 Mar; 266(8):5177-81. PubMed ID: 1848242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]